Alpha-lipoic acid treatment reduces the levels of advanced end glycation products in type 2 diabetes patients with neuropathy
To view a copy of this license, visit About this article Cite this article Sato, K., Saigusa, D., Kokubun, T
Because peptides typically break down quickly in the digestive tract, most are administered through injections
Later in the 21st century, the advancement in the field of neurosciences, especially in the mechanism of disease and diagnostic approaches, the development of drugs against various neurological disorders, especially epilepsy, got much attention, and within the last 3 decades, more than twenty drugs have been approved by the USFDA for the treatment of epilepsy (Perucca, 2021)